Skip to main content

Arbutus Biopharma Corp SC TO-I/A, filed Oct 1, 2026

Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma Corporation accepted 46,000,000 Shares at US$5.00 per Share, an aggregate US$230 million purchase price representing approximately 23 percent of its outstanding Shares; settlement is expected on or about October 5, 2026. AI summary

SC TO-I/A 2026-10-01
View Original
Added on October 18, 2026